Jardiance (empagliflozin) prior authorization denied appeal
SGLT2 inhibitor
Typical PA criteria
- Type 2 diabetes, heart failure, or CKD
- Step therapy with metformin
Why your PA was denied
- Metformin not trialed
- Non-formulary
Evidence that overturns the denial
- ✓Diagnosis codes
- ✓Metformin trial history
- ✓EMPA-REG citation for cardiovascular indication
Cardiovascular and renal indications expand approvals; cite the right trial.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Jardiance (empagliflozin) prior authorization denied?+
The most common reasons are: Metformin not trialed; Non-formulary. Your denial letter names the specific criteria you did not meet.
How do I appeal a Jardiance (empagliflozin) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Jardiance (empagliflozin) denial?+
Diagnosis codes; Metformin trial history; EMPA-REG citation for cardiovascular indication.
What if the plan excludes Jardiance (empagliflozin) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)